BIOMAT Database Logo BIOMAT Database Logo

Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation. 1986

J J Heger, and E N Prystowsky, and W M Miles, and D P Zipes

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000638 Amiodarone An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. Amiobeta,Amiodarex,Amiodarona,Amiodarone Hydrochloride,Amiohexal,Aratac,Braxan,Corbionax,Cordarex,Cordarone,Kordaron,L-3428,Ortacrone,Rytmarone,SKF 33134-A,Tachydaron,Trangorex,Hydrochloride, Amiodarone,L 3428,L3428,SKF 33134 A,SKF 33134A
D001572 Benzofurans Compounds that contain a BENZENE ring fused to a furan ring. Coumarones,Diphenylbenzofuran

Related Publications

J J Heger, and E N Prystowsky, and W M Miles, and D P Zipes
Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
November 1989, British heart journal,
J J Heger, and E N Prystowsky, and W M Miles, and D P Zipes
Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.
August 2010, Vascular health and risk management,
J J Heger, and E N Prystowsky, and W M Miles, and D P Zipes
Treatment of recurrent ventricular tachycardia and fibrillation with aprindine.
May 1977, The American journal of cardiology,
J J Heger, and E N Prystowsky, and W M Miles, and D P Zipes
Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia.
December 1980, American heart journal,
J J Heger, and E N Prystowsky, and W M Miles, and D P Zipes
Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
February 1989, Journal of the American College of Cardiology,
J J Heger, and E N Prystowsky, and W M Miles, and D P Zipes
Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
June 1984, The American journal of cardiology,
J J Heger, and E N Prystowsky, and W M Miles, and D P Zipes
Amiodarone administration for refractory ventricular fibrillation or pulseless ventricular tachycardia.
October 2016, Nursing,
J J Heger, and E N Prystowsky, and W M Miles, and D P Zipes
Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation.
December 1991, American heart journal,
J J Heger, and E N Prystowsky, and W M Miles, and D P Zipes
Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
May 1983, Pacing and clinical electrophysiology : PACE,
J J Heger, and E N Prystowsky, and W M Miles, and D P Zipes
Rapid control of recurrent ventricular tachycardia with oral amiodarone.
October 1982, British medical journal (Clinical research ed.),
Copied contents to your clipboard!